[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2632953B1 - Derives de la benzazepine et de la benzothiazepine a action therapeutique - Google Patents

Derives de la benzazepine et de la benzothiazepine a action therapeutique

Info

Publication number
FR2632953B1
FR2632953B1 FR898908204A FR8908204A FR2632953B1 FR 2632953 B1 FR2632953 B1 FR 2632953B1 FR 898908204 A FR898908204 A FR 898908204A FR 8908204 A FR8908204 A FR 8908204A FR 2632953 B1 FR2632953 B1 FR 2632953B1
Authority
FR
France
Prior art keywords
therapeutically active
benzothiazepine derivatives
benzazepine
active benzazepine
benzothiazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR898908204A
Other languages
English (en)
Other versions
FR2632953A1 (fr
Inventor
David Floyd
John Thomas Hunt
Spencer David Kimball
John Krapcho
Jagabandhu Das
George Charles Rovnyak
Joel Charles Barrish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2632953A1 publication Critical patent/FR2632953A1/fr
Application granted granted Critical
Publication of FR2632953B1 publication Critical patent/FR2632953B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
FR898908204A 1988-06-20 1989-06-20 Derives de la benzazepine et de la benzothiazepine a action therapeutique Expired - Fee Related FR2632953B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20852188A 1988-06-20 1988-06-20
US07/353,806 US4902684A (en) 1988-06-20 1989-05-22 Benzazepine and benzothiazepine derivatives

Publications (2)

Publication Number Publication Date
FR2632953A1 FR2632953A1 (fr) 1989-12-22
FR2632953B1 true FR2632953B1 (fr) 1992-05-29

Family

ID=26903265

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898908204A Expired - Fee Related FR2632953B1 (fr) 1988-06-20 1989-06-20 Derives de la benzazepine et de la benzothiazepine a action therapeutique

Country Status (29)

Country Link
US (1) US4902684A (fr)
JP (1) JP2793674B2 (fr)
KR (1) KR970002633B1 (fr)
CN (1) CN1027262C (fr)
AT (1) AT398567B (fr)
AU (1) AU614399B2 (fr)
BE (1) BE1003305A4 (fr)
CA (1) CA1336975C (fr)
CH (1) CH681723A5 (fr)
EG (1) EG19071A (fr)
ES (1) ES2016467A6 (fr)
FI (1) FI94246C (fr)
FR (1) FR2632953B1 (fr)
GB (1) GB2231329B (fr)
GR (1) GR1002099B (fr)
HU (1) HU210929B (fr)
IE (1) IE64242B1 (fr)
IL (1) IL90515A (fr)
IT (1) IT1230884B (fr)
LU (1) LU87865A1 (fr)
NL (1) NL8920642A (fr)
NO (1) NO179449C (fr)
NZ (1) NZ229612A (fr)
PL (1) PL162313B1 (fr)
PT (1) PT90914B (fr)
RU (1) RU2090562C1 (fr)
SE (1) SE9004060L (fr)
WO (1) WO1989012633A1 (fr)
YU (1) YU121389A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008284A (en) * 1989-02-15 1991-04-16 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4963671A (en) * 1989-11-20 1990-10-16 E. R. Squibb & Sons, Inc. Process for resolving chiral intermediates used in making calcium channel blockers
US5112969A (en) * 1990-04-02 1992-05-12 Merrell Dow Pharmaceuticals Inc. Cyano esters and azepinones
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato
CA2112360A1 (fr) * 1991-06-28 1993-12-23 William Edward Bondinell Antagonistes bicycliques du fibrinogene
IT1255545B (it) * 1992-10-23 1995-11-09 Procedimento per la preparazione di diltiazem
CA2098446A1 (fr) * 1992-09-30 1994-03-31 Eckard Weber 2,5-dihydro-2,5-dioxo-1h-azepines et 2,5-dihydro-2-oxo-1h-azepines et leur utilisation comme antagonistes des recepteurs de l'acide amine excitateur et de la glycine
DE69430483D1 (de) * 1993-07-16 2002-05-29 Merck & Co Inc Benzoxazinon- und Benzopyrimidinon- piperidinyl-Verbindungen als tokolytische Oxytocin-Rezeptor-Antagonisten
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
NZ282565A (en) * 1994-03-24 1999-11-29 Merrell Pharma Inc Condensed mercaptoacetylamidedisulphidebenzazepines used in treating elevated cholesterol levels, atherosclerosis, and hypotriglyceridemia
US5580867A (en) * 1994-09-09 1996-12-03 Universite De Montreal Myocardial protection during ischemia and reperfusion
AU733881B2 (en) * 1996-12-10 2001-05-31 Abbott Laboratories 3-pyridyl enantiomers and their use as analgesics
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
GB9907895D0 (en) * 1999-04-08 1999-06-02 Texas A & M Univ Sys Novel ligands for chiral catalysis
US6472533B1 (en) 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
CA2482320C (fr) * 2002-04-19 2010-02-09 Georg T. Wondrak Procedes de modulation de la phototoxicite

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312691A (en) * 1963-08-23 1967-04-04 Ciba Geigy Corp 2, 3, 4, 5-tetrahydro-1-benzazepin-2-ones
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS59191036A (ja) * 1983-04-14 1984-10-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
GB2154577A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co 1,5-benzothiazepines
GB2154578A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co Novel 1,5-benzothiazepine derivatives and processes for preparing the same
GB2167063A (en) * 1984-11-17 1986-05-21 Tanabe Seiyaku Co 6 or 9-chloro-1, 5-benzothiazepine derivatives
CA1271747A (fr) * 1985-06-12 1990-07-17 David M. Floyd Derives de benzazepines
US4748239A (en) * 1985-06-12 1988-05-31 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1271748C (fr) * 1985-12-12 1990-07-17 Derives de benzazepine
FR2597097B1 (fr) * 1986-04-15 1988-12-02 Synthelabo Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
DE3771143D1 (de) * 1986-08-20 1991-08-08 Mcneilab Inc Benzothiazepin-vasodilatoren mit aralkylsubstitution.
US4729994A (en) * 1986-08-20 1988-03-08 Mcneilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US4752645A (en) * 1986-10-09 1988-06-21 E. R. Squibb & Sons, Inc. Benzazepine derivatives
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones

Also Published As

Publication number Publication date
HUT59908A (en) 1992-07-28
AU614399B2 (en) 1991-08-29
FI94246B (fi) 1995-04-28
LU87865A1 (de) 1991-12-16
PL162313B1 (pl) 1993-09-30
NO905485L (no) 1991-02-19
IT8920933A0 (it) 1989-06-20
FR2632953A1 (fr) 1989-12-22
AT398567B (de) 1994-12-27
CN1027262C (zh) 1995-01-04
FI900813A0 (fi) 1990-02-19
NO179449B (no) 1996-07-01
GB2231329B (en) 1992-10-21
KR970002633B1 (en) 1997-03-06
RU2090562C1 (ru) 1997-09-20
US4902684A (en) 1990-02-20
BE1003305A4 (fr) 1992-02-25
SE9004060D0 (sv) 1990-12-19
JPH04502002A (ja) 1992-04-09
KR920700207A (ko) 1992-02-19
NO179449C (no) 1996-10-09
ATA901089A (de) 1994-05-15
PT90914A (pt) 1989-12-29
GR890100410A (el) 1990-05-11
CA1336975C (fr) 1995-09-12
HU894298D0 (en) 1991-01-28
GB2231329A (en) 1990-11-14
IL90515A (en) 1994-07-31
JP2793674B2 (ja) 1998-09-03
GB9002587D0 (en) 1990-08-29
IE891957L (en) 1989-12-20
CH681723A5 (fr) 1993-05-14
AU3859389A (en) 1990-01-12
IL90515A0 (en) 1990-01-18
SE9004060L (sv) 1992-06-20
IT1230884B (it) 1991-11-08
NZ229612A (en) 1992-07-28
WO1989012633A1 (fr) 1989-12-28
GR1002099B (en) 1995-12-28
IE64242B1 (en) 1995-07-26
CN1039585A (zh) 1990-02-14
FI94246C (fi) 1995-08-10
NO905485D0 (no) 1990-12-19
ES2016467A6 (es) 1990-11-01
EG19071A (en) 1994-07-30
PT90914B (pt) 1994-12-30
NL8920642A (nl) 1990-06-01
HU210929B (en) 1995-09-28
YU121389A (en) 1991-04-30

Similar Documents

Publication Publication Date Title
FR2632953B1 (fr) Derives de la benzazepine et de la benzothiazepine a action therapeutique
FR2631232B1 (fr) Adsorbats medicamenteux
DK514589D0 (da) Serviet
FR2645423B3 (fr) Sac de couchage
NO20021111L (no) Anvendelse av 5-O-deoaminyl-6-O-metylerytronolid A-derivater for fremstilling av biologisk aktive produkter
IL89804A0 (en) Biologically active proteins
LU90844I2 (fr) es Riamet et ses d-riv-s pharmaceutiquement acceptabl
DK82890D0 (da) Rullelegeme
FR2620711B1 (fr) Phosphinylcycloalkylcarbonyl et phosphinylcycloalcenylcarbonyl dipeptides a action therapeutique
FR2618150B1 (fr) Benzazepines 3-substituees a action therapeutique
DE59601169D1 (de) Rotierender zylindrischer Körper mit geringer Massenträgheit
FR2618777B1 (fr) Benzazepines a action therapeutique
FR2634207B1 (fr) Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique
FR2615511B1 (fr) Derives de benzazepines a action therapeutique
FR2638747B1 (fr) Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
EP0336619A3 (en) Optically active pyridylethanol derivatives
EP0366614A3 (en) Pharmaceutically active dithioketene derivatives
DK42889D0 (da) Thiazepinderivater
DE3990664T1 (de) Benzazepin- und benzothiazepin-derivate
DK296790D0 (da) Benzazepin- og benzothiazepinderivater
GB8823755D0 (en) Biologically & therapeutically active agents against hivs
SG171194G (en) Pharmaceutically active dithioketene derivatives
IL108254A0 (en) Biologically active conjugates
EP0334369A3 (en) Antiarteriosclerotic agent
GB8926713D0 (en) Biologically and therapeutically active agents against hiv-1

Legal Events

Date Code Title Description
ST Notification of lapse